Endometriosis-An Overview Prof. Dr. Mohammad A. Emam Prof. of Obstetrics and Gynecology Mansoura Faculty of Medicine Mansoura Integrated Fertility Center (MIFC) EgyptEmam MA, EGYPT, 2003
Endometriosis-An Overview
Prof. Dr. Mohammad A. Emam
Prof. of Obstetrics and Gynecology
Mansoura Faculty of Medicine
Mansoura Integrated Fertility Center (MIFC) Egypt
Emam MA, EGYPT, 2003
Definition
"Presence of endometrial tissue outside the lining of the uterine cavity" or
"Proliferation of endometrium in any site other than the uterine mucosa."
Epidemiology
• Age: common in reproductive period
• True Incidence Unknown: ? 1-5% & 30-50% infertility.
• Does NOT Discriminate by Race.
• Histology: Endometrial Glands with Strom +/- Inflammatory Reaction.
• Herdietary (↑↑ among sisters)
Sites
- Pelvic
- Extra pelvic
• Umbilicus.
• Scars (Lap.). • Lungs & plura.
• Others.
Pelvic Endometriosis
• Uterine= Adenomyosis (50%).
• Extraut:
- Ovary 30%
- Pelvic peritoneum 10%
- F. tube.
- Vagina.
- Bladder & rectum.
- Pelvic colon.
- Ligaments.
Emam,MA, EGYPT, 2003
Theories of histiogenesis
• Endometrial implantation theory
Retrograde
Vascular and lymphatic
Mechanical
• Immunological and genetic theory
• Composite theory
Theories of Histiogenesis
• In situ development
• Coelomic metaplasia theory
• Induction theory
• Embryonic cell nest
• Wolffian ducts
• Mullerian ducts
• Germinal epithelium of ovary
Predisposing Factors
1. Hyperoestrinism:
a) Fibroid & metropathia hemorrhagica.
b) Delayed marriage, inferility.
c) Oestrogen secreting tumours of the ovary e.g. granulosa & theca cell tumors, or with prolonged oestrogen therapy.
2. Cervical Stenosis.
3. Unsufflation.
4. Curettage.
Emam MA, EGYPT, 2003
Macroscopic appearance
1) Uterine endometriosis "Adenomyosis":
a) Diffuse (Common)
* The uterus is symmetrically enlarged
* Firm in consistency
b) Localized (occasional)
* The uterus is asymmetrical enlarged
* Firm in consistency
In both types:
C/S a whorled appearance.
D.D. * No capsule.
Dark brown spots.
* M/E endometrial tissue.
Emam MA, EGYPT, 2003
Macroscopic appearance
2) Endometriosis of the ovary:
- The ovary is enlarged and cystic.
- Surface burnt match head appearance.
- Tunica albuginea --> thickened.
• Chocolate or tarry cysts.
Emam MA, EGYPT, 2003
Diagnosis
• Endometriosis is often misdiagnosed leading to delays in treatment sometimes for several years.
• Delay in diagnosis:
- Progression of symptoms.
- Increasing infertility till completed reproductive failure.
Emam MA, EGYPT, 2003
Diagnosis
• Symptoms (history).
• Signs (Exam).
• Investigations.
• DD.
Symptoms
• Asymptomatic.
• Pain (DYS.....):
- Dysmenorrhea (crescendo=progressive)
- Dyspareunia.
- Dyschesia.
Dysuria.
• Backache.
• Acute abdomen.
• premenst. Tension syndrome.
Emam MA, EGYPT, 2003
Symptoms cont...
• Bleeding:
- Menorrhagia.
- Cyclic hematuria during menstration.
- Cyclic bleeding per rectum during menstration.
- Vicarious menstration.
• Infertility.
• Mass
Emam MA, EGYPT, 2003
Signs
Pelvic examination may reveal:
1. Pelvic tenderness.
2. Fixed retroverted uterus.
3. Nodularity of the Douglas pouch nd uteroscacral ligaments.
4. Ovaries may be enlarged and tender. Ovarian cyst may be detected.
Emam MA, EGYPT, 2003
Investigations
1. Laparoscopy.
2. Cystoscopy and proctosigmoidoscopy.
3. Histopathological examination.
4. Imaging.
5. Serum CA - 125.
6. ? IL-8 & CEA.
Emam MA, EGYPT, 2003
Laparoscopy
• Value:
It permits a "see and treat" approach, although its effectiveness may be limited by the nature of the disease and the surgeon's skill.
Laparoscopy
Appearance:
Endometriosis May Appear
• Brown
• Black ("Powderburn")
• Clear ("Atypical")
Endometriosis May be associated with Peritoneal windows
Emam MA, EGYPT, 2003
Differential diagnosis
1. Ovarian cysts.
2. Pelvic inflammatory disease.
3. Other causes of nodularity in Douglas pouch as tuberculous peritonitis and metastases of ovarian cancer.
4. Causes of haematuria, bleeding per rectum and acute abdominal pain if the patient is presented by one of these symptoms.
5. Asymmetrical enlarged uterus.
Emam MA, EGYPT, 2003
Ovarian Endometriosis (Endometrioma)
• Formed by invagination of the ovarian cortex after accumulation of menstrual debris from bleeding of endometriotic implants.
Emam MA, EGYPT, 2003
Rectovaginal Septum Endometriosis
• Nodules are formed by hyperplasia of smooth muscles and fibrous tissue surrounding the infiltrated tissue.
• No cyclical bleeding as the endometriotic tissue are enclosed in nodules.
Emam MA, EGYPT, 2003
Classification / Staging
• Several Proposed Schemes.
• Revised AFS System: Most Often Used.
• Ranges from Stage I (Minimal) to Stage IV (Severe).
• Staging Involves Location and Depth of Disease, Extent of Adhesions.
Emam MA, EGYPT, 2003
Revised AFS 1985
• Stage I (minimal) 1-5.
• Stage II (mild) 6-15.
• Stage III (moderate) 16-40.
• Stage IV (severe) > 40.
Emam MA, EGYPT, 2003
Treatment: Consideration
• Age.
• Symptoms.
• Stage.
Intertility.
Emam MA, EGYPT, 2003
Treatment (Rationale)
• Recognize Goals:
- Pain Management
- Preservation / Restoration of Fertility
• Discuss with Patient:
- Disease may be Chronic and Not Curable
- Optimal Treatment Unproven or Nonexistent
Edometriosis & IVF
• The presence of endometriosis does not generally impair the results of IVF but it increases the risk of infection.
• It is perferable not to cauterize ovarian endometrioma if IVF or ICSI is indicated for fear of destruction of ovarian tissues.
Emam MA, EGYPT, 2003
Lines of ttt
• Expectant.
• Medical.
• Hormonal.
• Surgical.
Emam MA, EGYPT, 2003
(I) Expectant treatment
• Young, asymptomatic infertile patient with mild endometriosis.
• If pregnancy does not achieved within 12-18 months of observation:
- hormonal or surgical treatment is indicated.
Emam MA, EGYPT, 2003
(II) Medical Treatment
• Symptomatizing patients with minimal or mild lesions:
1. Analgesics: for pain.
2. Prostaglandin inhibitors.
3. Pregnancy.
4. Opoids.
Emam MA, EGYPT, 2003
(III) Hormonal treatment
• Oestrogen.
• Combined oestrogen-progestogen pills.
• Progestins.
• Danazol.
GnRH agnotists.
Emam MA, EGYPT, 2003
Indications of Hormonal ttt
1. Small endometriotic; lesions.
2. Recurrence after conservative surgery.
3. Preoperative for 6-12 weeks to decrease size.
4. Postoperative for residual lesions.
5. When operation is contraindicated or refused by the patient.
Emam MA, EGYPT, 2003
Aim of the hormonal therapy
(A) Pseudopregnancy:
1. Combined low - dose contraceptive pills (6-18 months to inhibit ovulation and menstration and induce decidualization to endometriotic tissues).
or
2. Progestins (to avoid oestrogen's side effects medroxy progesterone acetate Depo medroxy progesterone acetate (DMPA) can be given in a dose of 150 mg IM every I-3 months.
Emam MA, EGYPT, 2003
Aim of the hormonal therapy
(B) Pseudomenopause (induction of amenorrhoea) by:
1. Danazol.
2. Gn RH analogues.
3. Gestrinone.
4. Gossypol.
Emam MA, EGYPT, 2003
Danazol
• Weak Androgen (isoxazole derivative of 16 - alpha ethinyl testosterone).
• Suppresses LH/FSH.
• Causes Endometrial Regression, Atrophy.
• Expensive.
• Dose 400- 800 mgm orally / day/ 6-9 months.
• Side-effects: Weight Gain, Masculinization, Occ. Permanent Vocal
Emam MA, EGYPT, 2003
GnRH-a
• Initially Stimulate FSH/LH Release.
• Down-Regulates GnRH Receptors-"Pseudomenopause".
• Long-term Success Varies.
• Expensive.
• Use Limited by Hypoestrogenic Effects.
• May be Combined with Add-Back (?>1 Year), using E2/progesterone preparation.
Emam MA, EGYPT, 2003
GnRH-a
Addback (E2/progesterone preparation):
• Reduce effect on bone mineral density.
• Relieve hot flushes.
Emam MA, EGYPT, 2003
Gossypol
• Is a phenolic compound extracted from the seed, stem and root of the cotton plant.
• It is a suppressor of FSH and LH, producing endometrial atrophy in about 50% of patients after 3 months.
• Dose: 20 mg daily for 2 months then 25 mg twice weekly for maintenance.
• Side effects: include electrolyte disturbance especially hypokalaemia and alteration of hepatic and renal function.
Emam MA, EGYPT, 2003
Gestrinone
• It is a synthetic 19 Nor steroid exhibits marked and progesterogenic and anti- oestrogenic as well as mild androgenic and anti-gonadotrophic properties
• The endocrine effects of Gestrinone are similar to those of Danazol which leads mainly to inhibition of ovarian steroidogenesis.
• The dose is 2.5 - 5 mg orally twice weekly.
Emam MA, EGYPT, 2003
Surgical Treatment (Laparoscopy /Laparotomy)
• Excision si/ Fulgeraton no!
• Resection of Endometrioma.
• Lysis of Adhesions, Cul-de-sac Reconstruction.
• Uterosacral Nerve Ablation.
• Presacral Neurectomy.
• Appendectomy.
• Uterine Suspension (? Efficacy).
• Hysterectomy +/- BSO.
Emam MA, EGYPT, 2003
Issues
• ? Removal of Ovaries at Hysterectomy
• ? Need for Progestins if ERT Given
• ? Adjuvant Treatment Postoperatively
• ? Lupron Challenges Test for Diagnosis
• • ? Is Endometriosis Best treated Surgically, Medically or Both
Conservative surgery
1. Large adnexal masses.
2. Failure of medical and hormonal treatment.
3. Severe endometriosis (follow principles of microsurgery).
Emam MA, EGYPT, 2003
The Principles of Microsurgical Technique
1. The use of magnification by microscope or head loupes.
2. gentle handling of tissues.
3. meticulous tissue dissection.
4. precise haemostasis.
5. careful approximation of tissues.
Emam MA, EGYPT, 2003
The Principles of Microsurgical Technique
6. Irrigation of the field with heparined Ringer's lactate.
7. The use of non- or delayed absorbable suture material, cut gut should be avoided as it is irritant to the tissue.
8. Contamination of the pelvis with foreign material as talc powder from gloves should be avoided as it provokes inflammation.
9. Intra- operative dextran 70.
10. postoperative corlicosteroids and prophylactic antibiotics may be used.
Emam MA, EGYPT, 2003
Conclusion
• Endometriosis is a mystery tour as it requires decision making at every stage by the physician and the patient.
• Endometriosis still stand as one of the most-investigated disorders in gynecology. So is one of the highest priorities for research.
Thank you
Prof. DR. MOHAMMAD EMAM,
OB& GYN, Mansoura Faculty of Medicine
Mansoura Integrated Fertility Center (MIFC) EGYPT
Telfax 0020502319922 & 002050231229
Email. mae335@hotmail.com
Emam MA, EGYPT, 2003
Recap on reproductive rights with David Hackney, MD, MS
December 20th 2022In this episode of Pap Talk, we spoke with David Hackney, MD, MS, maternal-fetal medicine physician at Case Western Reserve University and chair of ACOG's Ohio chapter for a full recap of where restrictions on reproductive rights have been and where they're going.
Listen
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
IUD placement within 48 hours nonsuperior vs 2 to 4 weeks after abortion
November 19th 2024A study reveals no significant difference in 6-month intrauterine device use between placements within 48 hours or 2 to 4 weeks after a second-trimester abortion, though earlier placement carries a higher expulsion risk.
Read More